Clinical trial
Open access
Aug 2026
18F-FDG PET/CT metabolic parameter to predict pathological complete response and survival after neoadjuvant immunotherapy plus chemoradiotherapy in resectable esophageal squamous cell carcinoma
Evaluating the diagnostic efficacy of 18F-FDG PET/CT for achieving pCR after nICRT for ESCC and its prognostic value for survival showed that patients with poorer OS and DFS had poorer prognostic factors for OS and DFS, but LnSUVmax2 has diagnostic value for lymph nodes metastasis.
Ji-Cheng Yang, Li Ma, Xiao-Ming Zhao et al.
· Cancer Imaging · 0 citations